BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9441344)

  • 1. [Cysteinyl-leukotrienes: important mediators in asthma].
    Louis R; Neven I; Quadvlieg V; Bettiol J; Radermecker M
    Rev Med Liege; 1997 Sep; 52(9):598-602. PubMed ID: 9441344
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathophysiology of the cysteinyl leukotrienes and effects of leukotriene receptor antagonists in asthma.
    Bisgaard H
    Allergy; 2001; 56 Suppl 66():7-11. PubMed ID: 11421935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cysteinyl leukotrienes in asthma: old mediators up to new tricks.
    Hay DW; Torphy TJ; Undem BJ
    Trends Pharmacol Sci; 1995 Sep; 16(9):304-9. PubMed ID: 7482995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cysteinyl leukotriene interactions with other mediators and with glucocorticosteroids during airway inflammation.
    Peters-Golden M; Sampson AP
    J Allergy Clin Immunol; 2003 Jan; 111(1 Suppl):S37-42; discussion S43-8. PubMed ID: 12532085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introduction: the anti-inflammatory role of cysteinyl leukotriene receptor antagonists in asthma.
    Holgate ST; Peters-Golden M
    J Allergy Clin Immunol; 2003 Jan; 111(1 Suppl):S1-4. PubMed ID: 12532082
    [No Abstract]   [Full Text] [Related]  

  • 6. [New developments in asthma therapy: how do individual leukotriene antagonists work?].
    Wagener M
    Praxis (Bern 1994); 1998 Feb; 87(8):271-5. PubMed ID: 9542455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukotrienes in respiratory disease.
    McMillan RM
    Paediatr Respir Rev; 2001 Sep; 2(3):238-44. PubMed ID: 12052325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory cells in asthma: mechanisms and implications for therapy.
    Hamid Q; Tulic' MK; Liu MC; Moqbel R
    J Allergy Clin Immunol; 2003 Jan; 111(1 Suppl):S5-S12; discussion S12-7. PubMed ID: 12532083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Status of leukotrienes in the pathophysiology of asthma. Necessity for antileukotrienes treatment].
    Fal AM; Kopeć A
    Pneumonol Alergol Pol; 2010; 78(1):68-73. PubMed ID: 20162521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of aspirin-intolerant asthma with antileukotrienes.
    Dahlén B
    Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 2):S137-41. PubMed ID: 10673243
    [No Abstract]   [Full Text] [Related]  

  • 11. The inflammatory response.
    Denburg JA
    Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 2):S11-3. PubMed ID: 8646373
    [No Abstract]   [Full Text] [Related]  

  • 12. [Sulfidopeptide leukotrienes and asthma].
    Dinh Xuan AT; Peiffer C; Marsac J; Lockhart A
    Rev Mal Respir; 1989; 6(6):483-91. PubMed ID: 2557653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cysteinyl leukotrienes and leukotriene receptor antagonists on markers of inflammation.
    Sampson AP; Pizzichini E; Bisgaard H
    J Allergy Clin Immunol; 2003 Jan; 111(1 Suppl):S49-59; discussion S59-61. PubMed ID: 12532086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intrinsic bronchial asthma].
    Kreukniet J; Remmert G
    Ned Tijdschr Geneeskd; 1986 Dec; 130(51):2298-301. PubMed ID: 3821949
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of mast cells and basophils in asthma.
    Redington AE; Polosa R; Walls AF; Howarth PH; Holgate ST
    Chem Immunol; 1995; 62():22-59. PubMed ID: 7546283
    [No Abstract]   [Full Text] [Related]  

  • 16. Leukotrienes: mediators of inflammation and immediate hypersensitivity reactions.
    Malmsten CL
    Crit Rev Immunol; 1984; 4(4):307-34. PubMed ID: 6325090
    [No Abstract]   [Full Text] [Related]  

  • 17. Cough, asthma, and cysteinyl-leukotrienes.
    Niimi A
    Pulm Pharmacol Ther; 2013 Oct; 26(5):514-9. PubMed ID: 23774534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Leukotriene antagonists: a new approach in the treatment of asthma].
    Devillier P; Bessard G; Advenier C
    Rev Mal Respir; 1997 Jun; 14(3):159-70. PubMed ID: 9411593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of montelukast and airway mast cell profiles in patients with cough variant asthma.
    Kawai S; Baba K; Matsubara A; Shiono H; Okada T; Yamaguchi E
    J Asthma; 2008 Apr; 45(3):243-50. PubMed ID: 18415834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bronchoprotective effects of leukotriene receptor antagonists in asthma: a meta-analysis.
    Currie GP; Lipworth BJ
    Chest; 2002 Jul; 122(1):146-50. PubMed ID: 12114350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.